Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Journal of Neuroscience Methods
|
September 4, 2017
Extended, continuous measures of functional status in community dwelling persons with Alzheimer's and related dementia: Infrastructure, performance, tradeoffs, preliminary data, and promise
Bradley Zylstra, George Netscher, Julien Jacquemot, et al.
Translational Oncology
|
January 5, 2021
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
Brendan P Hodkinson, Michael Schaffer, Joshua D Brody, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 18, 2020
Long-term digital device-enabled monitoring of functional status: Implications for management of persons with Alzheimer's disease
Natalie A Manley, Eléonore Bayen, Tamara L Braley, et al.
Nature Medicine
|
May 6, 2024
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial
Jordi Rodón, Silvia Damian, Muhammad Furqan, et al.
Nature Medicine
|
May 24, 2024
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial
Jordi Rodón, Silvia Damian, Muhammad Furqan, et al.
British Journal of Haematology
|
May 4, 2021
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib
Sriram Balasubramanian, Songbai Wang, Christopher Major, et al.
BMC Bioinformatics
|
March 8, 2020
CNV Radar: an improved method for somatic copy number alteration characterization in oncology
David Soong, Jeran Stratford, Herve Avet-Loiseau, et al.
Leukemia
|
August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Blood Advances
|
September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab
Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2016
Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
Weimin Li, Joyce O'Shaughnessy, Daniel Hayes, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Journal of Neuroscience Methods
|
September 4, 2017
Extended, continuous measures of functional status in community dwelling persons with Alzheimer's and related dementia: Infrastructure, performance, tradeoffs, preliminary data, and promise
Bradley Zylstra, George Netscher, Julien Jacquemot, et al.
Translational Oncology
|
January 5, 2021
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
Brendan P Hodkinson, Michael Schaffer, Joshua D Brody, et al.
Alzheimer'S & Dementia (New York, N. Y.)
|
June 18, 2020
Long-term digital device-enabled monitoring of functional status: Implications for management of persons with Alzheimer's disease
Natalie A Manley, Eléonore Bayen, Tamara L Braley, et al.
Nature Medicine
|
May 6, 2024
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial
Jordi Rodón, Silvia Damian, Muhammad Furqan, et al.
Nature Medicine
|
May 24, 2024
Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial
Jordi Rodón, Silvia Damian, Muhammad Furqan, et al.
British Journal of Haematology
|
May 4, 2021
Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib
Sriram Balasubramanian, Songbai Wang, Christopher Major, et al.
BMC Bioinformatics
|
March 8, 2020
CNV Radar: an improved method for somatic copy number alteration characterization in oncology
David Soong, Jeran Stratford, Herve Avet-Loiseau, et al.
Leukemia
|
August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Blood Advances
|
September 9, 2021
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab
Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 9, 2016
Biomarker Associations with Efficacy of Abiraterone Acetate and Exemestane in Postmenopausal Patients with Estrogen Receptor-Positive Metastatic Breast Cancer
Weimin Li, Joyce O'Shaughnessy, Daniel Hayes, et al.
Page
of 6